Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Experience of Endocrine Late Effects in Children with Haemolobinopathies Post Thiotepa Based Haematopoetic Stem Cell Transplant (HSCT) Regimens

Roochi Trikha, MB ChB, PhD, Catherine Hurley, Saji Alexander, Josu de la Fuente, Leena Karnik, MD FRCPath, MBBS,

Blood (2016) 128 (22): 5801.

https://doi.org/10.1182/blood.V128.22.5801.5801

Published: 2016

Journal Articles

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

Nathalie Dhedin, MD, Josu de la Fuente, Francoise Bernaudin, MD, Mathieu Kuentz, MD, Leena Karnik, MD FRCPath, MBBS,, Tatsuki Koyama, PhD, Robert A. Brodsky, MD, Michael DeBaun, MD, Adetola A. Kassim, MD MS

Blood (2016) 128 (22): 1233.

https://doi.org/10.1182/blood.V128.22.1233.1233

Published: 2016

Journal Articles

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in β Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD

Farah O'Boyle, PhD, Leena Karnik, MD FRCPath, MBBS,, Anne Bradshaw, Richard M Szydlo, Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath

Blood (2016) 128 (22): 1283.

https://doi.org/10.1182/blood.V128.22.1283.1283

Published: 2016

Journal Articles

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Matched and Single Antigen Mismatched Unrelated Bone Marrow Transplantation in Haemoglobinopathies Is Feasible and Leads to Early and Sustanined Engraftment with No Long-Term Toxicity or GvHD

Farah O'Boyle, PhD, Leena Karnik, MD FRCPath, MBBS,, Anne Bradshaw, Richard M Szydlo, Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath

Blood (2016) 128 (22): 2468.

https://doi.org/10.1182/blood.V128.22.2468.2468

Published: 2016

Journal Articles

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in Haemoglobinopathies Leads to Early and Sustanined Engraftment with Low Incidence of VOD and GvHD

Farah O'Boyle, PhD, Sandra Hing, PhD, Yvonne Harrington, Subarna Chakravorty, PhD FRCPath, Leena Karnik, MD FRCPath, MBBS,, Helen New, PhDFRCPath, Anne Bradshaw, Richard Szydlo, PhD, Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath

Blood (2015) 126 (23): 1906.

https://doi.org/10.1182/blood.V126.23.1906.1906

Published: 2015

Journal Articles

Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach Is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation

Josu de la Fuente, PhD FRCP, FRCPI, FRCPCH, FRCPath, Farah O'Boyle, PhD, Yvonne Harrington, Anne Bradshaw, Sandra Hing, PhD, Subarna Chakravorty, PhD FRCPath, Leena Karnik, MD FRCPath, MBBS,, Helen New, PhDFRCPath, Richard Szydlo, PhD, Baba PD Inusa, MBBS, FMCPaed, FRCPCH, MRCP, DCP, Paul Telfer, FRCPath,MD

Blood (2015) 126 (23): 4317.

https://doi.org/10.1182/blood.V126.23.4317.4317

Published: 2015

NARROW

Experience of Endocrine Late Effects in Children with Haemolobinopathies Post Thiotepa Based Haematopoetic Stem Cell Transplant (HSCT) Regimens

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in β Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Matched and Single Antigen Mismatched Unrelated Bone Marrow Transplantation in Haemoglobinopathies Is Feasible and Leads to Early and Sustanined Engraftment with No Long-Term Toxicity or GvHD

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in Haemoglobinopathies Leads to Early and Sustanined Engraftment with Low Incidence of VOD and GvHD

Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach Is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation

Email alerts

ASH Publications

American Society of Hematology

Experience of Endocrine Late Effects in Children with Haemolobinopathies Post Thiotepa Based Haematopoetic Stem Cell Transplant (HSCT) Regimens

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in β Thalassaemia Major Leads to Early and Sustained Engraftment with Low Incidence of VOD and GvHD

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Matched and Single Antigen Mismatched Unrelated Bone Marrow Transplantation in Haemoglobinopathies Is Feasible and Leads to Early and Sustanined Engraftment with No Long-Term Toxicity or GvHD

Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Related Transplantation in Haemoglobinopathies Leads to Early and Sustanined Engraftment with Low Incidence of VOD and GvHD

Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach Is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only